Inventor
GITZINGER MARC
CH13 patents
⚠️ This page may combine multiple inventors who share the name “GITZINGER MARC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BioVersys AG
11 patentsUS11766425B2Sep 26, 2023
Antibiotic combination therapies
BioVersys AG1 citations70
US11207305B2Dec 28, 2021
Antibiotic combination therapies
BioVersys AG2 citations70
US9682079B2Jun 20, 2017
Composition for treatment of pathogens that are resistant to tetracyclines
BioVersys AG4 citations64
US12403133B2Sep 2, 2025
Rifabutin treatment methods, uses, and compositions
BioVersys AG0 citations60
US11903934B2Feb 20, 2024
Rifabutin treatment methods, uses, and compositions
BioVersys AG0 citations60
US11344537B2May 31, 2022
Rifabutin treatment methods, uses, and compositions
BioVersys AG0 citations60
US12370184B2Jul 29, 2025
Antibiotic combination therapies
BioVersys AG0 citations59
US12257241B2Mar 25, 2025
Rifabutin treatment methods, uses, and compositions
BioVersys AG0 citations59
US11833139B2Dec 5, 2023
Rifabutin treatment methods, uses, and compositions
BioVersys AG0 citations59
US11351158B2Jun 7, 2022
Rifabutin treatment methods, uses, and compositions
BioVersys AG0 citations59
US12509462B2Dec 30, 2025
3-(phenylsulfonyl)-[1,2,3]triazolo[1,5A]quinazolin-5(4H)-one derivatives
BioVersys AG0 citations44